GlassScriptPhysician profile
Anail Cantu
NPI 1154903730
$1,554.86
in general payments reported to CMS, 2019-2025
23 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $173 · 2023: $472 · 2024: $511 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $267.14 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $242.64 | 2023-2025 | Aptima, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Astellas Pharma US INC | $196.56 | 2022-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $123.59 | 2023-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $105.13 | 2022-2024 | |
| Millicent US INC | $78.90 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Abbvie INC. | $75.75 | 2022-2023 | |
| Novo Nordisk INC | $61.81 | 2024 | Wegovy |
| Evofem Biosciences, INC. | $59.49 | 2023-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $42.16 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $42.06 | 2022-2023 | |
| Aspira Women'S Health INC | $33.97 | 2024-2025 | Ova1 |
| Smith+Nephew, INC. | $26.62 | 2023 | Pico 7 |
| Organon LLC | $24.82 | 2025 | Nexplanon |
| Agile Therapeutics, INC. | $23.39 | 2024 | Twirla |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $23.19 | 2022 | |
| Medicem INC. | $22.53 | 2022 | |
| Medtronic, INC. | $20.59 | 2023 | Truclear |
| Optumhealth Care Solutions, LLC | $19.69 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Shield Therapeutics INC | $19.36 | 2025 | |
| Merck Sharp & Dohme LLC | $16.91 | 2025 | Gardasil 9 |
| Coopersurgical, INC. | $15.42 | 2022 | |
| Myovant Sciences INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anail Cantu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.